BioPorto A/S (CPH:BIOPOR)
Denmark
· Delayed Price · Currency is DKK 1.496
-0.004 (-0.27%)
May 14, 2025, 11:39 AM CET
BioPorto Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 34.45 | 36.24 | 30.96 | 28.97 | 24.25 | 23.2 | Upgrade
|
| Revenue Growth (YoY) | 6.40% | 17.07% | 6.87% | 19.44% | 4.52% | -12.84% | Upgrade
|
| Cost of Revenue | 12.18 | 11.71 | 10.78 | 9.93 | 9.21 | 9.87 | Upgrade
|
| Gross Profit | 22.27 | 24.53 | 20.18 | 19.04 | 15.04 | 13.34 | Upgrade
|
| Selling, General & Admin | 65.54 | 66.45 | 54.9 | 63.05 | 50.04 | 48.8 | Upgrade
|
| Research & Development | 44.87 | 33.53 | 25.45 | 34.94 | 30.26 | 28.13 | Upgrade
|
| Operating Expenses | 110.41 | 99.98 | 80.35 | 97.99 | 80.3 | 76.93 | Upgrade
|
| Operating Income | -88.14 | -75.45 | -60.16 | -78.94 | -65.26 | -63.59 | Upgrade
|
| Interest Expense | -0.65 | -0.45 | -0.57 | -1.09 | -0.91 | -0.78 | Upgrade
|
| Interest & Investment Income | 1.64 | 1.64 | 1.04 | 0.04 | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.9 | 0.9 | -0.43 | 1.14 | 2.46 | -2.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.46 | -0.38 | -0.07 | -0.12 | -0.13 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -86.71 | -73.74 | -60.2 | -78.96 | -63.84 | -66.83 | Upgrade
|
| Asset Writedown | - | - | -1.01 | -2.58 | - | - | Upgrade
|
| Other Unusual Items | -3.4 | -0 | - | - | - | - | Upgrade
|
| Pretax Income | -90.11 | -73.74 | -61.21 | -81.55 | -63.84 | -66.83 | Upgrade
|
| Income Tax Expense | -7.96 | -5.5 | -4.88 | -5.62 | -6.73 | -5.27 | Upgrade
|
| Net Income | -82.15 | -68.24 | -56.33 | -75.92 | -57.11 | -61.56 | Upgrade
|
| Net Income to Common | -82.15 | -68.24 | -56.33 | -75.92 | -57.11 | -61.56 | Upgrade
|
| Shares Outstanding (Basic) | 435 | 406 | 358 | 319 | 267 | 205 | Upgrade
|
| Shares Outstanding (Diluted) | 435 | 406 | 358 | 319 | 267 | 205 | Upgrade
|
| Shares Change (YoY) | 21.12% | 13.18% | 12.54% | 19.11% | 30.21% | 20.53% | Upgrade
|
| EPS (Basic) | -0.19 | -0.17 | -0.16 | -0.24 | -0.21 | -0.30 | Upgrade
|
| EPS (Diluted) | -0.19 | -0.17 | -0.16 | -0.24 | -0.21 | -0.30 | Upgrade
|
| Free Cash Flow | -88.71 | -83.93 | -55.5 | -52.89 | -64.71 | -36.93 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.21 | -0.15 | -0.17 | -0.24 | -0.18 | Upgrade
|
| Gross Margin | 64.64% | 67.68% | 65.19% | 65.73% | 62.01% | 57.49% | Upgrade
|
| Operating Margin | -255.86% | -208.17% | -194.34% | -272.51% | -269.05% | -274.05% | Upgrade
|
| Profit Margin | -238.46% | -188.29% | -181.95% | -262.08% | -235.48% | -265.31% | Upgrade
|
| Free Cash Flow Margin | -257.51% | -231.58% | -179.26% | -182.58% | -266.79% | -159.16% | Upgrade
|
| EBITDA | -87.4 | -74.76 | -59.16 | -77.81 | -64.2 | -62.73 | Upgrade
|
| EBITDA Margin | -253.72% | -206.27% | -191.09% | -268.60% | -264.70% | -270.33% | Upgrade
|
| D&A For EBITDA | 0.74 | 0.69 | 1.01 | 1.13 | 1.05 | 0.86 | Upgrade
|
| EBIT | -88.14 | -75.45 | -60.16 | -78.94 | -65.26 | -63.59 | Upgrade
|
| EBIT Margin | -255.86% | -208.17% | -194.34% | -272.51% | -269.05% | -274.05% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.